Drug Shortage Report for BLEPHAMIDE

Last updated on 2021-07-30 History
Report ID 137389
Drug Identification Number 00807788
Brand name BLEPHAMIDE
Common or Proper name sulfacetamide/prednisolone
Company Name ALLERGAN INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) SULFACETAMIDE SODIUM PREDNISOLONE ACETATE
Strength(s) 10% 0.2%
Dosage form(s) DROPS
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ml and 10ml
ATC code S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-13
Estimated end date 2021-05-21
Actual end date 2021-05-25
Shortage status Resolved
Updated date 2021-07-30
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-07-30 French Compare
v7 2021-07-30 English Compare
v6 2021-06-23 English Compare
v5 2021-05-18 French Compare
v4 2021-05-18 English Compare
v3 2021-04-14 English Compare
v2 2021-04-13 French Compare
v1 2021-04-13 English Compare

Showing 1 to 8 of 8